Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 9;7(1):7633.
doi: 10.1038/s41598-017-07230-8.

Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications

Affiliations

Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications

Saket Gupta et al. Sci Rep. .

Erratum in

Abstract

The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective glucose metabolism, obesity, cardiovascular disease and an inability to mount an effective immune response to certain pathogenic organisms. Perturbations in key innate immune receptors known as Toll-like receptors (TLRs) and inflammatory mediators such as IL-6, TNFα and IL-1β have been linked with T2DM. Herein, we sought to establish whether patients with T2DM and underlying complications exhibit perturbations in cytokine and TLR expression. Serum cytokine and mRNA levels of cytokines/TLRs in monocytes (M) and neutrophils (N) were measured in a cohort of 112 diabetic patients: good glycaemic control without complications (GC), good glycaemic control with complications (GCC), poor glycaemic control without complications (PC) and poor glycaemic control with complications (PCC) and compared them with 34 non-diabetic volunteers (NGT). Serum cytokine levels were normal in all study participants. In the GC group, cytokine and TLR gene expression were enhanced compared to NGT. In contrast, suppressed cytokine and TLR gene expression were evident in PC, GCC & PCC groups when compared to the GC. In conclusion, whereas serum pro-inflammatory cytokine levels are unaltered in T2DM patients, differences in inflammatory gene profiles exist among the T2DM patient groups.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Levels of cytokines in sera from NGT and T2DM patients. TNF-α (A), IL-6 (B), IL-1β (C), IFN-β (D), IL-10 (E), Rantes (F), IL-8 (G) IL-12 (H) and IFNγ (I) levels in NGT (n = 34), GC (n = 27), GCC (n = 32), PC (n = 21) and PCC (n = 32) patient groups. *p < 0.05, **p < 0.01, ***p < 0.001 vs. NGT.
Figure 2
Figure 2
Gene expression of TNFα, IL-6, IL-1β, IFN-β and Rantes in monocytes and neutrophils from NGT and T2DM patients. Analysis of TNFα (A,F), IL-6 (B,G), IL-1β (C,H), IFN-β (D,I) and RANTES (E,J) gene expression in monocytes (AE) and neutrophils (FJ) from NGT and T2DM patients (n = 8 per group). Top and bottom horizontal lines of the boxplots indicate 25th and 75th percentiles respectively; lines within the box indicate median values. *p < 0.05, **p < 0.01, ***p < 0.001 vs NGT.
Figure 3
Figure 3
Gene expression of TLR1-10 in monocytes and neutrophils from NGT and T2DM patients. Analysis of TLR1 (A,K), TLR2 (B,L), TLR3 (C,M), TLR4 (D,N), TLR5 (E,O), TLR6 (F,P), TLR7 (G,Q), TLR8 (H,R), TLR9 (I,S), TLR10 (J,T) gene expression in monocytes (AJ) and neutrophils (KT) from NGT and T2DM patients (n = 8 per group). Top and bottom horizontal lines of the boxplots indicate 25th and 75th percentiles respectively; lines within the box indicate median values. *p < 0.05, **p < 0.01, ***p < 0.001 vs NGT.

References

    1. Guest CB, Park MJ, Johnson DR, Freund GG. The implication of proinflammatory cytokines in type 2 diabetes. Front Biosci. 2008;13:5187–5194. doi: 10.2741/3074. - DOI - PubMed
    1. Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian journal of endocrinology and metabolism. 2016;20:546–551. doi: 10.4103/2230-8210.183480. - DOI - PMC - PubMed
    1. Festa A, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) Circulation. 2000;102:42–47. doi: 10.1161/01.CIR.102.1.42. - DOI - PubMed
    1. Navarro JF, Mora C. Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. TheScientificWorldJournal. 2006;6:908–917. doi: 10.1100/tsw.2006.179. - DOI - PMC - PubMed
    1. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. The Journal of clinical endocrinology and metabolism. 2009;94:3171–3182. doi: 10.1210/jc.2008-2534. - DOI - PubMed

Publication types